CSIMarket
 


Pathfinder Cell Therapy, Inc.  (PFND)
Other Ticker:  
 

Pathfinder Cell Therapy's Quick Ratio

PFND's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2015, Quick Ratio fell to 0 a new company low.

Within Medical Equipment & Supplies industry 213 other companies have achieved higher Quick Ratio than Pathfinder Cell Therapy in third quarter 2015. While Quick Ratio total ranking has improved so far during the III Quarter 2015 to 5970, from total ranking in the second quarter 2015 at 6043.

Explain Quick Ratio?
How much Cash & cash equivalents PFND´s has?
What are PFND´s Current Liabilities?


PFND Quick Ratio (Sep 30 2015)
III. Quarter
(Jun 30 2015)
II. Quarter
(Mar 31 2015)
I. Quarter
(Dec 31 2014)
IV. Quarter
(Sep 30 2014)
III. Quarter
Y / Y Current Liabilities Change 18.34 % 19.32 % 21.79 % 28.54 % 47.42 %
Y / Y Cash & cash equivalent Change -82.61 % - -68.18 % -40.91 % -66.18 %
Quick Ratio MRQ 0 - 0 0 0
PFND's Total Ranking # 5970 # 6043 # 5030 # 5004 # 5010
Seq. Current Liabilities Change 4.3 % 2.93 % 4.23 % 5.75 % 5.17 %
Seq. Cash & cash equivalent Change - - -19.23 % 13.04 % 9.52 %



Quick Ratio third quarter 2015 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 214
Healthcare Sector # 934
Overall Market # 5970


Quick Ratio Statistics
High Average Low
0.05 0.01 0
(Jun 30 2012)   (Sep 30 2015)




Financial Statements
Pathfinder Cell Therapy's Current Liabilities $ 7 Millions Visit PFND's Balance sheet
Pathfinder Cell Therapy's Cash & cash equivalent $ 0 Millions Visit PFND's Balance sheet
Source of PFND's Sales Visit PFND's Sales by Geography


Cumulative Pathfinder Cell Therapy's Quick Ratio

PFND's Quick Ratio for the trailling 12 Months

PFND Quick Ratio

(Sep 30 2015)
III. Quarter
(Jun 30 2015)
II. Quarter
(Mar 31 2015)
I. Quarter
(Dec 31 2014)
IV. Quarter
(Sep 30 2014)
III. Quarter
Y / Y Current Liabilities TTM Growth 18.34 % 19.32 % 21.79 % 28.54 % 47.42 %
Y / Y Cash & cash equivalent TTM Growth -82.61 % - -68.18 % -40.91 % -66.18 %
Quick Ratio TTM 0 0 0 0.01 0.01
Total Ranking TTM # 3721 # 3995 # 3858 # 3870 # 3855
Seq. Current Liabilities TTM Growth 4.3 % 2.93 % 4.23 % 5.75 % 5.17 %
Seq. Cash & cash equivalent TTM Growth - - -19.23 % 13.04 % 9.52 %


On the trailing twelve months basis In Spite of the unchange in Current Liabilities in the III Quarter 2015 to $6.77 millions, cumulative Quick Ratio